A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.
Saved in:
| Title: | A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. |
|---|---|
| Authors: | Pandey K; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Wang SS; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia., Mifsud NA; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Faridi P; Monash Proteomics and Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; School of Clinical Sciences, Department of Medicine, Monash University, Clayton, VIC, Australia.; Department of Medicine, Sub-Faculty of Clinical and Molecular Medicine, Faculty of Medicine, Nursing & Health Sciences, Monash University, Clayton, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Medicine, School of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia., Davenport AJ; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Webb AI; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Sandow JJ; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Ayala R; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Monje M; Department of Neurology and Neurological Sciences and Howard Hughes Medical Institute, Stanford University, Stanford, CA, United States., Cross RS; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Ramarathinam SH; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Jenkins MR; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; LaTrobe Institute for Molecular Science, LaTrobe University, Bundoora, VIC, Australia., Purcell AW; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Aug 11; Vol. 13, pp. 1192448. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37637064 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pandey+K%22">Pandey K</searchLink>; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+SS%22">Wang SS</searchLink>; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mifsud+NA%22">Mifsud NA</searchLink>; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Faridi+P%22">Faridi P</searchLink>; Monash Proteomics and Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; School of Clinical Sciences, Department of Medicine, Monash University, Clayton, VIC, Australia.; Department of Medicine, Sub-Faculty of Clinical and Molecular Medicine, Faculty of Medicine, Nursing & Health Sciences, Monash University, Clayton, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Medicine, School of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Davenport+AJ%22">Davenport AJ</searchLink>; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Webb+AI%22">Webb AI</searchLink>; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Sandow+JJ%22">Sandow JJ</searchLink>; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ayala+R%22">Ayala R</searchLink>; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Monje+M%22">Monje M</searchLink>; Department of Neurology and Neurological Sciences and Howard Hughes Medical Institute, Stanford University, Stanford, CA, United States.<br /><searchLink fieldCode="AU" term="%22Cross+RS%22">Cross RS</searchLink>; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ramarathinam+SH%22">Ramarathinam SH</searchLink>; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Jenkins+MR%22">Jenkins MR</searchLink>; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; LaTrobe Institute for Molecular Science, LaTrobe University, Bundoora, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Purcell+AW%22">Purcell AW</searchLink>; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Aug 11; Vol. 13, pp. 1192448. <i>Date of Electronic Publication: </i>2023 Aug 11 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37637064 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2023.1192448 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1192448 Titles: – TitleFull: A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pandey K – PersonEntity: Name: NameFull: Wang SS – PersonEntity: Name: NameFull: Mifsud NA – PersonEntity: Name: NameFull: Faridi P – PersonEntity: Name: NameFull: Davenport AJ – PersonEntity: Name: NameFull: Webb AI – PersonEntity: Name: NameFull: Sandow JJ – PersonEntity: Name: NameFull: Ayala R – PersonEntity: Name: NameFull: Monje M – PersonEntity: Name: NameFull: Cross RS – PersonEntity: Name: NameFull: Ramarathinam SH – PersonEntity: Name: NameFull: Jenkins MR – PersonEntity: Name: NameFull: Purcell AW IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 08 Text: 2023 Aug 11 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
